Experienced and results-driven medical affairs professional with over 13 years in the pharmaceutical industry, currently serving as a Senior Regional Medical Advisor in the field of obesity at Novo Nordisk. Proven expertise in developing and executing regional medical strategies, leading pre-launch medical plans— including the successful preparation for Semaglutide 2.4 mg in the Central region—and engaging key stakeholders to support brand objectives. Strong background in cross-functional collaboration, hospital listing support, and scientific training of field teams. Adept at translating complex scientific data into actionable insights and fostering long-term partnerships with healthcare professionals. Known for adaptability, strategic thinking, and a collaborative leadership style in dynamic, fast-paced environments.